Skip to main content
Year archive

RACURA ONCOLOGY LTD — 2019 filings

All 74 regulatory filings released by RACURA ONCOLOGY LTD (RAC) in 2019, sourced directly from the official regulator.

74 Filings
2019 Period
2019 filings (74)
Filing Released Lang
Race Receives $159k R&D Tax Incentive Refund 1 page
Capital/Financing Update
2019-12-15 English
Appendix 3Y-Dr Daniel Tillett 2 pages 81.0KB
Director's Dealing
2019-12-04 English
Prof Borje Andersson to Chair Clinical Advisory Board 2 pages 107.3KB
Board/Management Information
2019-12-04 English
Appendix 3B 11 pages 247.6KB
Capital/Financing Update
2019-12-04 English
Race releases video of 2019 AGM presentation 1 page
AGM Information
2019-12-02 English
Appendix 3B-Issue of Options 11 pages 249.2KB
Share Issue/Capital Change
2019-11-25 English
Appendix 3Y-Dr Bill Garner 2 pages 28.3KB
Director's Dealing
2019-11-25 English
Replacement Appendix 3Y-Dr Bill Garner 2 pages 28.3KB
Director's Dealing
2019-11-25 English
Appendix 3Y-Dr John Cullity 2 pages 28.5KB
Director's Dealing
2019-11-25 English
Appendix 3Y-Dr Daniel Tillett 2 pages 80.8KB
Director's Dealing
2019-11-25 English
Appendix 3Y-Chris Ntoumenopoulos 2 pages 81.6KB
Director's Dealing
2019-11-25 English
Expiry of Unlisted Options 1 page 105.8KB
Capital/Financing Update
2019-11-24 English
Appendix 3Y-Chris Ntoumenopoulos 2 pages 28.7KB
Director's Dealing
2019-11-24 English
Annual General Meeting Presentation 32 pages 3.8MB
AGM Information
2019-11-21 English
Results of Annual General Meeting 2 pages 124.5KB
Declaration of Voting Results & Voting Rights Announcements
2019-11-21 English
Race reveals new strategy for cancer drug Bisantrene 27 pages 3.7MB
Investor Presentation
2019-11-13 English
Appendix 3Y-Dr Daniel Tillett 2 pages 27.4KB
Director's Dealing
2019-10-23 English
Appendix 4C - quarterly 5 pages 199.8KB
Interim / Quarterly Report Q1 2020
2019-10-16 English
Notice of Annual General Meeting/Proxy Form 31 pages 961.2KB
AGM Information
2019-10-16 English
Annual Report to shareholders 59 pages 1.0MB
Annual Report FY 2019
2019-10-16 English
Appendix 3B 11 pages 253.0KB
Capital/Financing Update
2019-10-13 English
Cleansing Notice 1 page 102.6KB
Capital/Financing Update
2019-10-13 English
Appendix 3Y-Dr Bill Garner 2 pages 28.5KB
Director's Dealing
2019-10-13 English
Appendix 3Y-Dr John Cullity 2 pages 28.4KB
Director's Dealing
2019-10-13 English
Appendix 3Y-Chris Ntoumenopoulos 2 pages 29.0KB
Director's Dealing
2019-10-13 English
Change in substantial holding 2 pages 133.6KB
Major Shareholding Notification
2019-10-13 English
Results of Meeting 2 pages 120.2KB
Declaration of Voting Results & Voting Rights Announcements
2019-10-08 English
Race appoints Dr Daniel Tillett Chief Scientific Officer 2 pages 98.9KB
Board/Management Information
2019-09-30 English
Notification of 2019 Annual General Meeting Date 1
AGM Information
2019-09-26 English
Director Appointment-Clarification 1 page 90.7KB
Board/Management Information
2019-09-18 English
Dr Daniel Tillett Joins Race Board 2 pages 97.5KB
Board/Management Information
2019-09-16 English
Initial Director's Interest Notice 2 pages 71.0KB
Director's Dealing
2019-09-16 English
Notice of General Meeting/Proxy Form 21 pages 821.4KB
Proxy Solicitation & Information Statement
2019-09-05 English
Appendix 3B 11 pages 249.5KB
Capital/Financing Update
2019-08-26 English
Cleansing Notice 1 page 104.3KB
Share Issue/Capital Change
2019-08-26 English
Appendix 4E & Annual Report 61 pages 1.0MB
Annual Report FY 2019
2019-08-22 English
Appendix 4G 9 pages 366.1KB
Governance Information
2019-08-22 English
Prominent biotech investor leads investment in Race 2 pages 116.6KB
Capital/Financing Update
2019-08-19 English
Appendix 3B 12 pages 192.0KB
Capital/Financing Update
2019-08-19 English
Cleansing Notice 1 page 140.1KB
Capital/Financing Update
2019-08-19 English
Information Required under ASX Listing Rule 3.10.5A 1
Capital/Financing Update
2019-08-19 English
Becoming a substantial holder 2 pages 80.7KB
Major Shareholding Notification
2019-08-19 English
Change in substantial holding 2 pages 60.8KB
Major Shareholding Notification
2019-08-19 English
Trading Halt 2 pages 167.8KB
Capital/Financing Update
2019-08-15 English
Race announces additional US Patent for Bisantrene 1
Regulatory Filings
2019-08-12 English
Appendix 3Y-Dr William Garner 2 pages 29.0KB
Director's Dealing
2019-08-06 English
Appendix 4C - quarterly 5 pages 119.4KB
Interim / Quarterly Report Q4 2019
2019-07-29 English
First patient treated in Bisantrene trial in Israel 2 pages 96.1KB
Regulatory Filings
2019-07-24 English
Appendix 3B 11 pages 108.8KB
Share Issue/Capital Change
2019-07-11 English
Cleansing Notice 1 page 139.6KB
Capital/Financing Update
2019-07-11 English
Appendix 3Y-Dr William Garner 2 pages 28.3KB
Director's Dealing
2019-07-11 English
Change in substantial holding 2 pages 64.3KB
Major Shareholding Notification
2019-07-11 English
Ceasing to be a substantial holder 3 pages 119.7KB
Major Shareholding Notification
2019-07-11 English
Appendix 3Y-Dr William Garner 2 pages 28.2KB
Director's Dealing
2019-07-04 English
Appendix 3Y-Dr William Garner 2 pages 28.8KB
Director's Dealing
2019-06-27 English
Change in substantial holding 2 pages 63.3KB
Major Shareholding Notification
2019-06-27 English
Appendix 3B 11 pages 110.0KB
Capital/Financing Update
2019-05-30 English
Bisantrene AML trial to start in Israel 3 pages 109.8KB
Regulatory Filings
2019-05-13 English
Bisantrene IND Update 2 pages 98.2KB
Regulatory Filings
2019-04-23 English
Appendix 4C - quarterly 5 pages 200.3KB
Interim / Quarterly Report Q3 2019
2019-04-11 English
Race files Bisantrene IND with FDA 2 pages 101.6KB
Capital/Financing Update
2019-03-24 English
Appendix 3B 11 pages 112.2KB
Capital/Financing Update
2019-03-12 English
Appendix 4D & Half-Year Financial Statements 22 pages 1.1MB
Interim / Quarterly Report H1 2019
2019-02-26 English
Principal Investigator appointed for Bisantrene 2 pages 122.3KB
Regulatory Filings
2019-02-24 English
Appendix 3Y-Dr William Garner 2 pages 28.0KB
Director's Dealing
2019-02-13 English
Change of Director's Interest Notice-Dr William Garner 2 pages 27.9KB
Director's Dealing
2019-02-11 English
Change of Director's Interest Notice-Mr Peter Molloy 2 pages 26.1KB
Director's Dealing
2019-02-11 English
Change of Director's Interest Notice-Mr Chris Ntoumenopoulos 2 pages 27.9KB
Director's Dealing
2019-02-11 English
Change in substantial holding 2 pages 57.9KB
Major Shareholding Notification
2019-02-11 English
Race Receives $228k R&D Tax Incentive Refund 1 page
Regulatory Filings
2019-01-30 English
Appendix 4C - quarterly 5 pages 109.2KB
Interim / Quarterly Report Q2 2018
2019-01-24 English
Appendix 3B 11 pages 156.4KB
Capital/Financing Update
2019-01-21 English
Race appoints leading haematologist to support Bisantrene 2 pages 122.0KB
Board/Management Information
2019-01-21 English
Change of Director's Interest Notice-Dr William Garner 2 pages 27.9KB
Director's Dealing
2019-01-06 English